Forefront Wealth Management Inc. / ABT
Forefront Wealth Management Inc.’s Abbott Laboratories Position
Does Forefront Wealth Management Inc. own Abbott Laboratories (ABT)? Yes — 18.8K shares worth $2M (+1.69% of its 13F portfolio) as of Q4 2025, down from 18.9K shares the prior filed quarter.
Position Value
$2M
Q4 2025
Shares
18.8K
% of Portfolio
+1.69%
Quarters Held
13
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 18.8K | $2M | +1.69% |
| Q3 2025 | 18.9K | $3M | +1.85% |
| Q2 2025 | 18.9K | $3M | +2.06% |
| Q1 2025 | 18.9K | $3M | +2.32% |
| Q4 2024 | 18.9K | $2M | +1.97% |
| Q3 2023 | 19.8K | $2M | +2.69% |
| Q2 2023 | 19.8K | $2M | +2.85% |
| Q1 2023 | 19.8K | $2M | +2.62% |
| Q4 2022 | 19.8K | $2M | +2.93% |
| Q3 2022 | 20.0K | $2M | +2.70% |
| Q2 2022 | 30.1K | $3M | +4.40% |
| Q1 2022 | 30.2K | $4M | +3.54% |
| Q4 2021 | 30.1K | $4M | +4.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forefront Wealth Management Inc.’s full portfolio or all institutional holders of ABT.